Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions
Corteva and Globachem plan a 50/50 JV targeting late-stage crop protection technologies for Europe and the Americas, with products expected from the early 2030s.
Rhea-AI Summary
Corteva (CTVA) and Globachem agreed on Sept. 9, 2026 to form a 50/50 joint venture for new crop protection products.
The independently operated JV will leverage late‑pipeline to commercial‑stage technologies from both parents to develop, register and market differentiated formulated crop protection solutions for farmers in Europe and the Americas. Products generated may be commercialized independently by one or both parent companies through their existing commercial channels.
The venture builds on an existing multi‑year collaboration between the companies and aims to accelerate delivery of tailored solutions for core crops. First new solutions from the JV are expected to launch in the early 2030s. Closing of the transaction is targeted for the fourth quarter of 2026, subject to required regulatory clearances and approvals.
Positive
- Creation of a 50/50 joint venture with independent operations
- JV targets Europe and the Americas for new crop protection solutions
- Builds on an existing multi-year partnership, enabling immediate collaboration benefits
- First JV-developed solutions are expected to launch in the early 2030s
Negative
- JV transaction closing is subject to regulatory clearances and approvals
- New solutions from the JV are not expected until the early 2030s
Key Figures
- Joint venture ownership
- 50/50
- Corteva and Globachem joint venture
- Expected closing
- Q4 2026
- Subject to regulatory clearances and approvals
- Expected product launches
- Early 2030s
- New crop protection solutions developed by the JV
Previous Partnership Reports
-
Earlier 50:50 JV targeted crop-based feedstock supply
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
JV to amplify both companies' complementary expertise to develop, scale, deliver differentiated crop protection solutions in high-growth markets
The new JV will be independently operated and focus on leveraging late-pipeline to commercial-stage technology from its parent companies to amplify both companies' ability to develop, register, and market the resulting products, which may be commercialized independently by one or both parent companies.
"This is the latest example of how we're leveraging collaborations to strengthen and broaden our portfolio as we prepare to launch as a standalone crop protection company following our planned separation," said Corteva Senior Vice President Brook Cunningham. "By combining our industry-leading pipeline and innovation capabilities with Globachem's expertise in formulation, we aim to scale and accelerate the delivery of more tailored, comprehensive solutions for core crops in targeted markets."
The JV will build upon an existing, multi-year partnership between Corteva and Globachem, allowing both companies to immediately benefit through enhanced collaboration. New solutions developed by the JV are expected to launch in the early 2030s and will be sold through established commercial channels.
"The entry into a definitive agreement regarding the establishment of the JV represents an important milestone in our long-standing relationship with Corteva and reflects our shared belief that collaboration is the fastest way to bring meaningful innovation to farmers," said Koen Quaghebeur, Chief Visionary Officer and Co-founder of Globachem. "Together, Corteva's world-class discovery and development capabilities and Globachem's expertise in product development, formulation and regulatory execution, create a powerful platform for innovation. The JV will accelerate the delivery of differentiated crop protection solutions that help growers address evolving agronomic challenges and seize new opportunities. We are excited to build a company that brings together the strengths of both organizations, creating sustainable value for growers, our partners, and both parent companies."
The transaction is currently expected to close in the fourth quarter of 2026, subject to all necessary regulatory clearances and approvals.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, hightouch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
About Globachem
Globachem N.V. is a family-owned crop protection company headquartered in Belgium, committed to helping growers and distribution partners tackle some of agriculture's most critical challenges. Built on scientific expertise with a strong customer focus, the company delivers practical, user-friendly solutions through a unique portfolio of established products and innovations. Active in more than 60 countries, Globachem is a trusted long-term partner, driven by service, collaboration and a continuous search for breakthrough solutions that make a meaningful difference in key crops worldwide. Learn more at www.globachem.com.
Cautionary statement
This release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "may," "expects," "will," "aims," "believes," "intends," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the parties' expectations related to regulatory matters, product development and commercialization, product offerings and product, financial or sustainability performance are forward-looking statements. No obligation to update or revise any forward-looking statement, except as required by applicable law, is hereby undertaken and any such obligation is specifically disclaimed. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, and as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K.
View original content to download multimedia:https://www.prnewswire.com/news-releases/corteva-globachem-enter-into-definitive-agreement-to-form-a-joint-venture-to-advance-development-commercialization-of-new-formulated-crop-protection-solutions-302872566.html
SOURCE Corteva Agriscience